Skip to main content
Fig. 3 | BMC Psychiatry

Fig. 3

From: Treatment with aripiprazole once-monthly injectable formulation is effective in improving symptoms and global functioning in schizophrenia with and without comorbid substance use – a post hoc analysis of the ReLiAM study

Fig. 3

Change in Clinical Global Impression Scale – Severity (CGI-S) over Time in Substance Users and Non-Users. A Patients reporting any substance use at baseline. B Patients reporting alcohol use at baseline. C Patients reporting cannabis use at baseline

Back to article page

BMC Psychiatry

ISSN: 1471-244X

Contact us